KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,461,085 | -49.9% | 105,114 | -17.1% | 0.00% | – |
| Q2 2023 | $2,914,121 | -68.4% | 126,756 | -59.3% | 0.00% | -100.0% |
| Q1 2023 | $9,220,175 | +26.8% | 311,177 | +6.8% | 0.00% | -50.0% |
| Q4 2022 | $7,271,098 | +290.1% | 291,310 | +240.3% | 0.00% | – |
| Q3 2022 | $1,864,000 | +6.5% | 85,604 | +107.1% | 0.00% | – |
| Q1 2022 | $1,750,000 | -68.8% | 41,340 | -53.2% | 0.00% | – |
| Q4 2021 | $5,610,000 | +292.9% | 88,398 | +263.7% | 0.00% | – |
| Q3 2021 | $1,428,000 | -33.9% | 24,304 | -45.4% | 0.00% | – |
| Q2 2021 | $2,161,000 | +44.7% | 44,553 | +15.9% | 0.00% | – |
| Q1 2021 | $1,493,000 | – | 38,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |